Durvalumab vs Pentamidine Isethionate

Durvalumab vs Pentamidine Isethionate: Overview

This comparison examines the pharmacological differences between Durvalumab and Pentamidine Isethionate.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Durvalumab — 17 days.

Chemical Properties

Type: Durvalumab — Antibody; Pentamidine Isethionate — Small molecule.